Management of Epigastric Pain Radiating to Back with Gas Formation and Dyspepsia

Immediate Priority: Exclude Life-Threatening Causes

The American College of Gastroenterology recommends obtaining an ECG within 10 minutes to exclude myocardial infarction, which presents atypically with epigastric pain in women, diabetics, and elderly patients, with mortality rates of 10-20% if missed 2, 3
Checking vital signs immediately for tachycardia ≥110 bpm, fever ≥38°C, or hypotension, which predict perforation or sepsis with high specificity, is crucial 1, 3
Ordering serum lipase or amylase (≥2x normal for lipase, ≥4x normal for amylase) to diagnose acute pancreatitis, which characteristically presents with epigastric pain radiating to the back and has 80-90% sensitivity and specificity, is essential 1, 2, 3
Performing a physical examination looking specifically for peritoneal signs (rigidity, rebound tenderness, absent bowel sounds) suggesting perforated peptic ulcer, which has 30% mortality if treatment is delayed, is vital 2, 3

Complete blood count, C-reactive protein, serum lactate, liver and renal function tests should be conducted to exclude serious organic pathology 1, 3
Serum electrolytes and glucose should be tested for all patients with epigastric pain and associated symptoms 1, 3
CT abdomen/pelvis with IV contrast is the gold standard when diagnosis is unclear, identifying pancreatitis (mortality <10% overall but 30-40% in necrotizing pancreatitis), perforation (showing extraluminal gas in 97%, fluid/fat stranding in 89%, ascites in 89%), and vascular emergencies 1, 2, 3

For patients ≥55 years with dyspepsia, the British Society of Gastroenterology recommends performing 2-week wait endoscopy if weight loss is present, or non-urgent endoscopy if treatment-resistant dyspepsia or raised platelet count 4, 5, 6
Patients <55 years without alarm symptoms (weight loss, anemia, dysphagia, persistent vomiting, hematemesis) can proceed directly to empirical management, as most patients with dyspepsia (80%) will have functional dyspepsia as the underlying cause after investigation 4, 5, 6
The American Gastroenterological Association recommends starting with "test and treat" for H. pylori using breath or stool testing (not serology), followed by high-dose PPI therapy if symptoms persist after successful eradication 6

The European Society of Gastrointestinal Endoscopy suggests using carbon-urea breath testing or fecal antigen testing (not serology, which has lower specificity) for H. pylori diagnosis 6
If H. pylori positive, triple therapy with Omeprazole 20 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg, all twice daily for 10 days, is recommended 6
Network meta-analysis shows "test and treat" ranks first in reducing symptoms at 12 months (RR 0.89; 95% CI 0.78-1.0) 6
Omeprazole 20 mg once daily before meals for 4-8 weeks is recommended as first-line for ulcer-like dyspepsia (epigastric pain/burning) 7, 8
Healing rates are 80-90% for duodenal ulcers, 70-80% for gastric ulcers 1, 3

For predominant fullness, bloating, or early satiety (postprandial distress syndrome), consider prokinetic agents after PPI trial, though options are limited due to cisapride cardiac toxicity 7, 8
If no response to initial PPI therapy after 2-4 weeks, switch drug class or increase dosing 7, 8
Pain unrelated to defecation favors functional dyspepsia over IBS 5
Burning sensation starting in epigastrium but radiating to chest suggests GERD over functional dyspepsia 5

For nausea, Ondansetron 8 mg sublingual every 4-6 hours (obtain baseline ECG due to QTc prolongation risk), promethazine 12.5-25 mg orally/rectally every 4-6 hours, or prochlorperazine 5-10 mg every 6-8 hours are recommended 1, 3

Never dismiss cardiac causes in patients with "atypical" epigastric pain regardless of age—obtain ECG and serial troponins at 0 and 6 hours 2, 3
Do not attribute persistent vomiting to functional dyspepsia—Rome IV criteria state this suggests another disorder and mandates investigation for structural disease 1
Do not delay endoscopy in patients with alarm features (weight loss, anemia, dysphagia, persistent vomiting, age ≥55 years), as missing gastric cancer or perforated ulcer leads to poor outcomes 5, 6, 2
Avoid NSAIDs, which worsen peptic ulcer disease and are associated with dyspepsia in multiple population-based studies 5, 3
Do not use H. pylori serology for test-and-treat strategy—use breath or stool testing only 6